Kelly Lawrence W & Associates Inc Amgen Inc Transaction History

Kelly Lawrence W & Associates Inc

$429 Million
Q1 2024

A detailed history of Kelly Lawrence W & Associates Inc transactions in Amgen Inc stock. As of the latest transaction made, Kelly Lawrence W & Associates Inc holds 1,826 shares of AMGN stock, worth $564,927. This represents 0.12% of its overall portfolio holdings.

Number of Shares

1,826

Previous 1,826 -0.0%

Holding current value

$564,927

Previous $525,000 1.14%

% of portfolio

0.12%

Previous 0.13%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $19,284 - $22,803	-90 Reduced 4.7%	1,826 $405,000
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $65,044 - $82,646	-284 Reduced 12.91%	1,916 $503,000
Q3 2022 Nov 15, 2022	BUY	$224.46 - $253.15 $15,712 - $17,720	70 Added 3.29%	2,200 $496,000
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $184,186 - $203,758	-840 Reduced 28.28%	2,130 $515,000
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $59,664 - $68,280	-300 Reduced 9.17%	2,970 $668,000

Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $231,452 - $269,719	1,043 Added 46.83%	3,270 $813,000
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $340,798 - $405,830	-1,575 Reduced 41.43%	2,227 $512,000
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $7,912 - $9,709	40 Added 1.06%	3,802 $897,000
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $303,458 - $354,233	-1,701 Reduced 31.14%	3,762 $733,000
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $55,587 - $62,666	300 Added 5.81%	5,463 $1.13 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $49,815 - $55,953	-300 Reduced 5.49%	5,163 $953,000
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $5,082 - $5,940	-30 Reduced 0.55%	5,463 $931,000
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $24,474 - $27,345	145 Added 2.71%	5,493 $955,000
Q3 2017 Nov 15, 2017	BUY	$167.29 - $191.0 $894,666 - $1.02 Million	5,348	5,348 $997,000

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $165B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Lawrence W & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Lawrence W & Associates Inc with notifications on news.

Account

Kelly Lawrence W & Associates Inc Amgen Inc Transaction History